Component information
Different name of ingredient
- Immunoglobulin G1, anti-(human integrin LPAM-1 (lymphocyte Peyer s patch adhesion molecule 1)) (human-Mus musculus heavy chain), disulfide with human-Mus musculus κ-chain, dimer
- MLN0002 (Takeda)
- MLN02
- LDP02
- Vedolizumabum
- Immunoglobulin G1-kappa, anti-[Homo sapiens alpha4 beta7 integrin (lymphocyte Peyer s patch adhesion molecule 1, LPAM-1)], humanized monoclonal antibody; gamma1 heavy chain (1-451) [humanized VH (Homo sapiens IGHV1-3*01 (84.70%)-(IGHD)-IGHJ4*01) [8.8.14] (1-121)-Homo sapiens IGHG1*01, CH2 L1.2>A, G1>A (122-451)], (224-219 )-disulfide with kappa light chain (1 -219 ) [humanized V-KAPPA (Homo sapiens IGKV2-29*02 (84.00%)-IGKJ2*01, L124>V) [11.3.9] (1 -112 )-Homo sapiens IGKC*01 (113 -219 )]; (230-
- Vedolizumab
Alternative medicine with selected ingredient
Name | PZN | Form | Packing | Manufacturer | Price | |
---|---|---|---|---|---|---|
Details | ENTYVIO 300 mg Plv.f.e.Konz.z.Her.e.Inf.-Lsg.Dsfl. | P18307236 | PKI | 1 St | HAEMP | € 2420.96 |
Details | ENTYVIO 300 mg Plv.f.e.Konz.z.Her.e.Inf.-Lsg.Dsfl. | P16388271 | PIK | 1 St | NMGPH | € 2417.13 |
Details | ENTYVIO 108 mg Injektionslösung i.e.Fertigspritze | P17845210 | ILO | 1 St | KOHL | € 620.59 |
Details | ENTYVIO 108 mg Injektionslösung i.e.Fertigspritze | P19797053 | ILO | 6 St | ORI | € 3602.63 |
Details | ENTYVIO 300 mg Plv.f.e.Konz.z.Her.e.Inf.-Lsg.Dsfl. | P16869378 | PIK | 1 St | ABACU | € 2420.61 |
Details | ENTYVIO 108 mg Injektionslösung i.e.Fertigspritze | P17822491 | ILO | 6 St | ABACU | € 3602.44 |
Details | ENTYVIO 108 mg Injektionslösung i.e.Fertigspritze | P15894569 | ILO | 1 St | TAKEK | € 0.00 |
Details | ENTYVIO 300 mg Plv.f.e.Konz.z.Her.e.Inf.-Lsg.Dsfl. | P10272142 | PIK | 1 St | TAKEK | € 0.00 |
Details | ENTYVIO 300 mg Plv.f.e.Konz.z.Her.e.Inf.-Lsg.Dsfl. | P16889441 | PIK | 1 St | KOHL | € 2420.86 |